|
| Chkmate on resistance to kinase inhibitors |
|
https://doi.org/10.18632/oncotarget.25802
Paul Shapiro
|
| 31560-31561 |
|
| CSCs: regenerating optimism for osteosarcoma treatment |
|
https://doi.org/10.18632/oncotarget.25820
Adam S. Levin
|
| 31562-31563 |
|
| The path to « the Golden Age » for the treatment of metastatic renal cell carcinoma |
|
https://doi.org/10.18632/oncotarget.25832
Gilles Pagès
|
| 31564-31565 |
|
| Are membranes nonapoptotic compartments for apoptotic caspases |
|
https://doi.org/10.18632/oncotarget.25796
Andreas Bergmann
|
| 31566-31567 |
|
| Copy number of latent viruses oncogenicity and the microcompetition model |
|
https://doi.org/10.18632/oncotarget.25804
Hanan Polansky, and Hava Schwab
|
| 31568-31569 |
|
| AMPK activates DAPK2 to promote autophagy |
|
https://doi.org/10.18632/oncotarget.25842
Ruth Shiloh, and Adi Kimchi
|
| 31570-31571 |
|
| Palbociclib resistance confers dependence on an FGFRMAP kinasemTORdriven pathway in KRASmutant nonsmall cell lung cancer |
|
https://doi.org/10.18632/oncotarget.25803
Eric Haines, Ting Chen, Naveen Kommajosyula, Zhao Chen, Grit S. Herter-Sprie, Liam Cornell, Kwok-Kin Wong, and Geoffrey I. Shapiro
|
| 31572-31589 |
|
| Resistance to complement activation cell membrane hypersialylation and relapses in chronic lymphocytic leukemia patients treated with rituximab and chemotherapy |
|
https://doi.org/10.18632/oncotarget.25657
Anne Bordron, Cristina Bagacean, Audrey Mohr, Adrian Tempescul, Boutahar Bendaoud, Stéphanie Deshayes, Florence Dalbies, Caroline Buors, Hussam Saad, Christian Berthou, Jacques-Olivier Pers, and Yves Renaudineau
|
| 31590-31605 |
|
| Genomic alterations at the basis of treatment resistance in metastatic breast cancer: clinical applications |
|
https://doi.org/10.18632/oncotarget.25810
Angela Toss, Federico Piacentini, Laura Cortesi, Lucia Artuso, Isabella Bernardis, Sandra Parenti, Elena Tenedini, Guido Ficarra, Antonino Maiorana, Anna Iannone, Claudia Omarini, Luca Moscetti, Massimo Cristofanilli, Massimo Federico, and Enrico Tagliafico
|
| 31606-31619 |
|
| A comprehensive evaluation of Hippo pathway silencing in sarcomas |
|
https://doi.org/10.18632/oncotarget.25824
Nicole M. Merritt, Colleen A. Fullenkamp, Sarah L. Hall, Qining Qian, Chandni Desai, Jon Thomason, Allyn M. Lambertz, Adam J. Dupuy, Benjamin Darbro, and Munir R. Tanas
|
| 31620-31636 |
|
| FGFR1/FOXM1 pathway: a key regulator of glioblastoma stem cells radioresistance and a prognosis biomarker |
|
https://doi.org/10.18632/oncotarget.25827
Valérie Gouazé-Andersson, Marie-Julie Ghérardi, Anthony Lemarié, Julia Gilhodes, Vincent Lubrano, Florent Arnauduc, Elizabeth Cohen-Jonathan Moyal, and Christine Toulas
|
| 31637-31649 |
|
| Impact of distress screening algorithm for psychooncological needs in neurosurgical patients |
|
https://doi.org/10.18632/oncotarget.25833
Marion Rapp, Stephanie Schipmann, Kira Hoffmann, Rainer Wiewrodt, Hans-Jakob Steiger, Marcel Kamp, Walter Stummer, Dorothee Wiewrodt, and Michael Sabel
|
| 31650-31663 |
|
| Inbornlike errors of metabolism are determinants of breast cancer risk clinical response and survival: a study of human biochemical individuality |
|
https://doi.org/10.18632/oncotarget.25839
Ismael da Silva, Rene da Costa Vieira, Carolina Stella, Edson Loturco, André Lopes Carvalho, Carlos Veo, Cristovam Neto, Sandra M. Silva, Paulo D'Amora, Marcia Salzgeber, Delcio Matos, Celso R. Silva, Jose R. Oliveira, Iara Rabelo, Patricia Yamakawa, Rui Maciel, Rosa Biscolla, Maria Chiamolera, Renato Fraietta, Felipe Reis, Marcelo Mori, Dirce Marchioni, Antonio Carioca, Gustavo Maciel, Renato Tomioka, Edmund Baracat, Clovis Silva, Celso Granato, Ricardo Diaz, Bruno Scarpellini, Daniel Egle, Heidi Fiegl, Irmgard Himmel, Christina Troi, and Robert Nagourney
|
| 31664-31681 |
|
| Paradoxical counteraction by imatinib against cell death in myeloid progenitor 32D cells expressing p210BCRABL |
|
https://doi.org/10.18632/oncotarget.25849
Morichika Takita, Fujiko Tsukahara, Taishi Mishima, Katsuaki Ieguchi, Masayuki Yamada, Hiroaki Honda, and Yoshiro Maru
|
| 31682-31696 |
|
| Suppression of SOCS3 enhances TRAILinduced cell growth inhibition through the upregulation of DR4 expression in renal cell carcinoma cells |
|
https://doi.org/10.18632/oncotarget.25851
Michihiro Yabe, Kei Ishibashi, Akifumi Onagi, Ryo Tanji, Ruriko Honda-Takinami, Tomoyuki Koguchi, Kanako Matsuoka, Seiji Hoshi, Junya Hata, Masao Kataoka, Soichiro Ogawa, Hiroyuki Hiraki, Nobuhiro Haga, and Yoshiyuki Kojima
|
| 31697-31708 |
|
| A Phase Ib openlabel dosefinding study of alpelisib in combination with paclitaxel in patients with advanced solid tumors |
|
https://doi.org/10.18632/oncotarget.25854
Jordi Rodon, Giuseppe Curigliano, Jean-Pierre Delord, Wael Harb, Analia Azaro, Yu Han, Celine Wilke, Valerie Donnet, Dalila Sellami, and Thaddeus Beck
|
| 31709-31718 |
|
| DNA Repair Molecular Beacon assay: a platform for realtime functional analysis of cellular DNA repair capacity |
|
https://doi.org/10.18632/oncotarget.25859
Jianfeng Li, David Svilar, Steven McClellan, Jung-Hyun Kim, Eun-Young Erin Ahn, Conchita Vens, David M. Wilson III, and Robert W. Sobol
|
| 31719-31743 |
|
| Advantages of systematic trunk SPECT/CT to planar bone scan PBS in more than 300 patients with breast or prostate cancer |
|
https://doi.org/10.18632/oncotarget.25860
Vincent Fleury, Ludovic Ferrer, Mathilde Colombié, Daniéla Rusu, Maëlle Le Thiec, Françoise Kraeber-Bodéré, Loïc Campion, and Caroline Rousseau
|
| 31744-31752 |
|
| A novel fatty acidbinding protein 5estrogenrelated receptor α signaling pathway promotes cell growth and energy metabolism in prostate cancer cells |
|
https://doi.org/10.18632/oncotarget.25878
Shogo Senga, Koichiro Kawaguchi, Narumi Kobayashi, Akira Ando, and Hiroshi Fujii
|
| 31753-31770 |
|
| Liver metastasis of pancreatic cancer: the hepatic microenvironment impacts differentiation and selfrenewal capacity of pancreatic ductal epithelial cells |
|
https://doi.org/10.18632/oncotarget.25884
Hendrike Knaack, Lennart Lenk, Lisa-Marie Philipp, Lauritz Miarka, Sascha Rahn, Fabrice Viol, Charlotte Hauser, Jan-Hendrik Egberts, Jan-Paul Gundlach, Olga Will, Sanjay Tiwari, Wolfgang Mikulits, Udo Schumacher, Jan G. Hengstler, and Susanne Sebens
|
| 31771-31786 |
|
| Correction: Halofuginone inhibits radiotherapyinduced epithelialmesenchymal transition in lung cancer |
|
https://doi.org/10.18632/oncotarget.25958
Yang Chen, Weishuai Liu, Peng Wang, Hailing Hou, Ningbo Liu, Linlin Gong, Youyou Wang, Kai Ji, Lujun Zhao, and Ping Wang
|
| 31787-31787 |
|
| Correction: Colon cancerinduced interleukin35 inhibits betacatenin mediated prooncogenic activity |
|
https://doi.org/10.18632/oncotarget.25959
Yueqiang Jiang, Yanling Ma, RuiChao Li, and JianHai Sun
|
| 31788-31788 |
|
| Correction: Characterization of HBV integration patterns and timing in liver cancer and HBVinfected livers |
|
https://doi.org/10.18632/oncotarget.25960
Mayuko Furuta, Hiroko Tanaka, Yuichi Shiraishi, Takuro Uchida, Michio Imamura, Akihiro Fujimoto, Masahi Fujita, Aya Sasaki-Oku, Kazuhiro Maejima, Kaoru Nakano, Yoshiiku Kawakami, Koji Arihiro, Hiroshi Aikata, Masaki Ueno, Shinya Hayami, Shun-Ichi Ariizumi, Masakazu Yamamoto, Kunihito Gotoh, Hideki Ohdan, Hiroki Yamaue, Satoru Miyano, Kazuaki Chayama, and Hidewaki Nakagawa
|
| 31789-31789 |
